I-KaiBiLi Flu & Covid-19 Antigen Duo Rapid Test
Intshayelelo
Iimpawu zeklinikhi kunye neempawu zosulelo lwentsholongwane yokuphefumla ngenxa ye-SARS-CoV-2 kunye nomkhuhlane zinokufana.I-SARS-CoV-2, umkhuhlane A kunye ne-antigens yentsholongwane yomkhuhlane B zibonwa ngokubanzi kwisampulu yokuphefumla ephezulu ngexesha lenqanaba elibukhali losulelo.
Intsholongwane yoMkhuhlane yeyosapho lwe-Orthomyxoviridae, kunye ne-immunologically eyahlukeneyo, intsholongwane ye-RNA enemisonto enye.Kukho intsholongwane yomkhuhlane A kunye no-B yeyona pathogen iphambili kwizigulo eziqatha ebantwini nakwiintlobo ezininzi zezilwanyana.Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela liyi-1 ukuya kwiintsuku ezi-4.Izibonakaliso eziphambili ziquka umkhuhlane obukhali, ubuhlungu obuqhelekileyo kunye neempawu zokuphefumla.Zombini ezi ntsholongwane zohlobo A no-B zinokujikeleza ngaxeshanye, kodwa ngokuqhelekileyo uhlobo olunye lulawula ngexesha elithile lonyaka.1
I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla.Ngokuqhelekileyo abantu basengozini.Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo;abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo.Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7.Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo.Ukuxinana kweempumlo, impumlo evuzayo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.
KaiBiLiTMUvavanyo lweFlu & COVID-19 Antigen Duo Rapid Test lwenzelwe ukufunyaniswa komgangatho ngaxeshanye kunye nokwahlulwa kwe-nucleocapsid protein antigens ukusuka kwi-SARS-CoV-2, umkhuhlane A kunye nomkhuhlane B kwimizekelo ethe ngqo ye-nasopharyngeal (NP).Ukufunyaniswa kusekelwe kwii-antibodies eziphuhliswe ngokukodwa ukuqaphela kunye nokusabela kunye ne-nucleoprotein yentsholongwane.
Ukufunyanwa
KaiBiLiTMUmkhuhlane kunye ne-COVID-19 ye-Antigen Duo Rapid Test kukufumanisa umgangatho ngaxeshanye kunye nomahluko we-nucleocapsid protein antigens ukusuka kwi-SARS-CoV-2, umkhuhlane A kunye nomkhuhlane B kwimizekelo ethe ngqo ye-nasopharyngeal (NP).
Umzekelo
Nasopharyngeal
Umda wokuFumana (LoD)
I-SARS-CoV-2 & Flu: 140 TCID50/mL
Umkhuhlane A
| Uxinzelelo lweNtsholongwane yoMkhuhlane | Ukubalwa kwe-LOD (TCID50/mL) |
| A/New Caledonia/20/1999_H1N1 | 8.50x103 |
| A/California/04/2009_H1N1 | 2.11x103 |
| A/PR/8/34_H1N1 | 2.93x103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
| A/Guizhou/54/89_H3N2 | 3.95x102 |
| A/Human/Hubei/3/2005_H3N2 | 2.93x104 |
| A/Bar-headed Goose/QH/BTY2/2015_H5N1 | 1.98x105 |
| A/Anhui/1/2013_H7N9 | 7.90x105 |
Umkhuhlane B.
| Uxinzelelo lweNtsholongwane yoMkhuhlane | KubaliweLOD(I-TCID50/mL) |
| B/Victoria | 4.25x103 |
| B/Yamagata | 1.58x102 |
Ukuchaneka
| Umkhuhlane A | Umkhuhlane B | I-COVID-19 | |
| Uvakalelo olunxulumeneyo | 86.80% | 91.70% | 96.60% |
| Inkcazelo ngokuthe ngqo | 94% | 97.50% | 100% |
| Ukuchaneka | 92.20% | 96.10% | 98.90% |
Ixesha leZiphumo
Funda iziphumo ngemizuzu eyi-15 kwaye ungabi ngaphezu kwemizuzu engama-30.
Iimeko zokugcina iikhithi
2–30°C.
Imixholo
| Izixhobo zovavanyo | Iimvavanyo ezingama-20 |
| Iiswabs ezisterilized | 20 iipcs. |
| Iityhubhu zokutsalwa (kunye ne-0.5mL yesithinteli sokutsalwa) | 20 iipcs. |
| Nozzle ngesihluzo | 20 iipcs. |
| Ukuma kweTubhu | iipcs ezi-1. |
| Faka ipakethe | iipcs ezi-1. |
Ukuodola Ulwazi
| Imveliso | Ikati.No. | Imixholo |
| KaiBiLiTMUmkhuhlane & COVID-19 Antigen Duo | P211137 | Iimvavanyo ezingama-20 |
